
Images are for product identification. Refer to the selected batch for packaging and availability.
Eurepa Mf 2
Drug Formula unavailable
YOUR PURCHASE PRICE
7 in stockInclusive of all taxes
Available batch
1 offerSign in to order for your pharmacy.
Product information
- Manufacturer
- Torrent Pharmaceuticals Ltd
- Category
- Allopathy
- Composition
- Not provided
- Packaging
- 10 TABLET
- Box / case pack
- 1 / —
Description
EUREPA MF 2 Tablet
EUREPA MF 2 Tablet is a combination oral anti-diabetic medication manufactured by Torrent Pharmaceuticals Ltd., used for the management of type 2 diabetes mellitus in adults. It is prescribed when diet, exercise, and single-drug therapy are insufficient to control blood sugar levels.
-
Composition: Each film-coated tablet contains Repaglinide U.S.P. 2 mg and Metformin Hydrochloride I.P. 500 mg.
-
Uses: EUREPA MF 2 is primarily used for the control of blood sugar levels in adults with type 2 diabetes mellitus. It aids in improving glycemic control and preventing complications associated with diabetes.
-
Dosage and Administration: This medicine should be taken orally, typically 2 to 3 times a day, within 30 minutes before a meal, or as advised by a doctor. Tablets should be swallowed whole with water and not crushed or chewed. Dosage is individualized based on the patient's condition and response. If a meal is skipped, the dose for that meal should also be skipped.
-
Side Effects: Common side effects may include hypoglycemia (low blood sugar), diarrhea, nausea, vomiting, abdominal pain, and headache. Serious but rare side effects like lactic acidosis can occur, particularly in patients with kidney, heart, or liver issues.
-
Precautions: EUREPA MF 2 is contraindicated in individuals with known allergies to its components, severe kidney impairment, metabolic acidosis (including diabetic ketoacidosis), and congestive heart failure. Caution is advised during pregnancy and breastfeeding; consultation with a doctor is essential. Excessive alcohol intake should be avoided as it increases the risk of lactic acidosis and hypoglycemia. Patients should monitor blood sugar levels regularly, and the medicine is not recommended for children.
-
Storage: Store EUREPA MF 2 Tablets at room temperature, ideally below 30°C, protected from moisture and humidity. Keep the medicine in a tight, light-resistant container and out of reach of children.
Frequently asked questions
Here are some frequently asked questions about Eurepa MF 2 by Torrent Pharmaceuticals Ltd.
What is EUREPA MF 2 used for?
EUREPA MF 2 Tablet is primarily used to treat type 2 diabetes mellitus in adults. This medication helps control blood sugar levels, especially when diet and exercise alone are not sufficient. It also aids in preventing complications associated with diabetes, such as kidney damage and blindness.
How does EUREPA MF 2 work?
EUREPA MF 2 is a combination medicine containing Repaglinide (2mg) and Metformin Hydrochloride (500mg). Repaglinide works by stimulating the pancreas to release more insulin, which helps reduce blood sugar levels after meals. Metformin works by decreasing the liver's production of glucose, delaying glucose absorption from the intestines, and increasing the body's sensitivity to insulin. Together, these two ingredients help achieve better control of blood sugar.
What is the usual dosage of EUREPA MF 2?
EUREPA MF 2 should be taken as advised by your doctor. It is typically recommended to take the medicine 2 to 3 times a day, within 30 minutes before a meal. The tablet should be swallowed whole with a glass of water and not crushed, broken, or chewed. The dosage is individualized based on the patient's condition, effectiveness, and tolerability. Do not exceed the prescribed dose.
What are the possible side effects of EUREPA MF 2?
Common side effects of EUREPA MF 2 include hypoglycemia (low blood sugar), taste change, nausea, vomiting, diarrhea, stomach pain, headache, and upper respiratory symptoms. Hypoglycemia symptoms can include sweating, shakiness, dizziness, confusion, and rapid heartbeat. Some serious but rare side effects can include lactic acidosis, severe allergic reactions, and abnormal liver tests. Most common side effects are temporary and resolve over time; however, if they persist or worsen, consult your doctor.
Is EUREPA MF 2 safe during pregnancy or breastfeeding?
EUREPA MF 2 is generally considered unsafe for use during pregnancy as it may cause harmful effects on the fetus. It is also probably unsafe to use during breastfeeding, as its components may excrete via breast milk. Always consult your doctor if you are pregnant, planning to get pregnant, or are breastfeeding to discuss appropriate alternatives or adjustments to your medication.
Can EUREPA MF 2 be taken with other medications?
Yes, EUREPA MF 2 can interact with certain other medicines. For instance, cationic medications (like amiloride, digoxin, ranitidine) and other hypoglycemic agents (like glipizide, insulin) can interact with EUREPA MF 2, potentially increasing the risk of low blood sugar or affecting the levels of the medicines. It is crucial to inform your doctor about all other medications, supplements, or herbal products you are taking to avoid potential drug interactions.
What precautions should be taken while using EUREPA MF 2?
Several precautions should be taken:
- Alcohol: Avoid or limit alcohol consumption while taking EUREPA MF 2, as it can increase the risk of lactic acidosis and hypoglycemia.
- Kidney and Liver Issues: Use EUREPA MF 2 with caution if you have kidney or liver disease. It is not recommended for those with severe kidney impairment or active liver diseases. Your doctor may need to adjust the dose or monitor kidney/liver function regularly.
- Driving: Your ability to drive or operate machinery may be affected if your blood sugar levels are too low or too high. Use caution or avoid these activities until you know how the medicine affects you.
- Other Conditions: Inform your doctor if you have metabolic acidosis, diabetic ketoacidosis, congestive heart failure, or are allergic to any components of the medicine.
- Hypoglycemia: Be aware of hypoglycemia symptoms and always carry a fast-acting source of sugar (like glucose tablets or fruit juice) in case you experience them.
What happens if a dose of EUREPA MF 2 is missed?
If you forget a dose of EUREPA MF 2, take it as soon as you remember. However, if it is almost time for your next dose or if you skip a meal, skip the missed dose and continue with your regular schedule. Do not take a double dose to make up for a missed one.
How should EUREPA MF 2 be stored?
EUREPA MF 2 tablets should be stored at room temperature, ideally below 30°C. It should be protected from moisture and humidity and kept in a tight, light-resistant container to avoid direct sunlight. Always keep this medicine out of the reach of children.